A phase II trial to study the combined chemotherapy with S-1 , irinotecan plus bevacizumab in patients with metastatic colorectal cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2015
At a glance
- Drugs Bevacizumab (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Irinotecan (Primary)
- Indications Colon cancer
- Focus Therapeutic Use
- 01 Sep 2015 New trial record